PM2.5 Exposure Amplifies IL-33-Mediated Airway Inflammation via NF-kB Signaling in Genetically Susceptible Individuals

Central Question

How does ambient PM2.5 exposure interact with genetic variation in IL33 and NF-κB pathway genes to amplify airway inflammation and asthma risk?

Background

Asthma is a multifactorial disease shaped by genetic susceptibility and environmental exposures. Genome-wide association studies have identified IL33 and related type 2 pathway genes as major asthma risk loci. IL-33 functions as an epithelial alarmin released upon cell damage or stress, activating group 2 innate lymphoid cells (ILC2s), mast cells, and Th2 lymphocytes via the ST2 receptor. Ambient fine particulate matter (PM2.5) induces oxidative stress and NF-κB activation in airway epithelium, leading to pro-inflammatory cytokine production. Epidemiological and experimental evidence suggests that PM2.5 exacerbates asthma and that genetic variants increasing IL33 expression may amplify this interaction. This brief synthesizes the mechanistic chain linking PM2.5 exposure to IL-33–driven airway inflammation through NF-κB signaling, with implications for gene–environment interaction (G×E) in asthma susceptibility.

Evidence Summary

  • GWAS: IL33 variants (rs1888909, rs928413) associated with asthma risk; enhancer-blocking regulatory mechanism alters IL33 expression (Nature Comms 2021, doi:10.1038/s41467-021-26347-z)
  • eQTL: IL33 shows strong lung and bronchial epithelium eQTL in GTEx; asthma-risk alleles correlate with elevated IL-33 in plasma and airway
  • In vitro: PM2.5 induces NF-κB activation in human airway epithelial cells via ROS-mediated IKK activation; miR-331 downregulation relieves IKK-β inhibition (Env Toxicol Pharmacol 2017, doi:10.1016/j.etap.2017.02.011)
  • In vivo: Ambient particulate matter exacerbates airway inflammation in experimental asthma models in an IL-33–dependent manner (Clin Exp Immunol 2014, doi:10.1111/cei.12348)
  • Epidemiological: G×E studies show GSTP1 and TNF variants modify air pollution–asthma associations; IL33 G×E data emerging (EHP 2014, doi:10.1289/ehp.1307459)

Mechanistic Chain

  1. 1. PM2.5 deposits in airways; oxidative stress (ROS) generated via particle surfaces and inflammatory cell activation
  2. 2. ROS activate IKK complex; miR-331 downregulation removes brake on IKK-β
  3. 3. NF-κB (RelA/p65) translocates to nucleus; induces IL33, IL6, IL8, TNF transcription
  4. 4. IL-33 released from damaged/stressed epithelial cells
  5. 5. IL-33 binds ST2 receptor on ILC2s, mast cells, Th2 lymphocytes
  6. 6. Th2 cascade: IL-4, IL-5, IL-13 production; eosinophil recruitment
  7. 7. Eosinophilic inflammation, goblet cell hyperplasia, airway remodeling
  8. 8. Airway hyperresponsiveness and asthma symptoms/exacerbations

Tissue Specificity

Primary events occur in bronchial epithelium (PM2.5 deposition, NF-κB activation, IL-33 release). Submucosal mast cells and ILC2s are activated locally. Regional lymph nodes may amplify Th2 priming. Genetic susceptibility is most relevant in epithelium where IL33 eQTLs are active.

Counterarguments / Limitations

  • Most G×E evidence for PM2.5 and asthma focuses on GSTP1 and TNF; direct IL33 × PM2.5 interaction in human cohorts is limited; in vivo models use high doses that may not reflect typical ambient exposure.
  • IL-33 can be released by multiple mechanisms (necrosis, active secretion, protease cleavage); the relative contribution of NF-κB–driven transcription vs. passive release from damaged cells remains debated.

Validation Criteria

  • Prospective cohort with GWAS-derived IL33/NF-κB PRS and repeated PM2.5 exposure assessment; test for PRS × PM2.5 interaction on asthma incidence and exacerbation
  • Human bronchial epithelial cells with asthma-risk vs. protective IL33 genotypes; expose to physiologically relevant PM2.5 doses; quantify IL-33 release and NF-κB activation
  • IL-33 blockade (anti–IL-33 or anti-ST2) in PM2.5-exposed asthma model; assess whether inflammation and AHR are attenuated

References

  1. 1.Li R, et al. (2017). Exposure to PM2.5 induces aberrant activation of NF-κB in human airway epithelial cells by downregulating miR-331 expression. Environmental Toxicology and Pharmacology. doi:10.1016/j.etap.2017.02.011
  2. 2.Brandenburg AH, et al. (2014). Ambient particulate matter induces an exacerbation of airway inflammation in experimental asthma: role of interleukin-33. Clinical & Experimental Immunology. doi:10.1111/cei.12348
  3. 3.Alvarez M, et al. (2021). Asthma-associated genetic variants induce IL33 differential expression through an enhancer-blocking regulatory region. Nature Communications. doi:10.1038/s41467-021-26347-z
  4. 4.Islam T, et al. (2014). GSTP1 and TNF Gene Variants and Associations between Air Pollution and Incident Childhood Asthma. Environmental Health Perspectives. doi:10.1289/ehp.1307459
  5. 5.Cayrol C, Girard JP (2018). The IL-33/ST2 axis: Role in health and disease. Cytokine & Growth Factor Reviews. doi:10.1016/j.cytogfr.2018.01.001